Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
Sponsor: Assiut University
Summary
To evaluate the role of regulatory B cells in the pathogenesis of metabolic associated fatty liver disease patients.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
174
Start Date
2023-12-01
Completion Date
2024-12-01
Last Updated
2024-07-30
Healthy Volunteers
Yes
Conditions
Interventions
regulatory B cell by flow cytometry
4-Evaluation of the Frequency of regulatory B cells (Bregs) by Flow Cytometry Using flow cytometry, circulating Bregs will be detected using FITC-conjugated-CD38, PE-conjugated-CD24 (Bioscience, USA), and PerCP-conjugated CD19 (BD Bioscience, USA). Briefly, 100 µl of blood sample will be incubated with 10 µL of CD24, CD38 and CD19 for 20 minutes at 4 °C in the dark. Following incubation, RBCs will be lysed and washed. Cells will be fixed and permeabilized then stained with APC-conjugated IL-10 (BD Bioscience, San Jose, CA, USA) and analysis will be done by FACS Calibur flow cytometry with CellQuest software (Becton Dickinson Biosciences, San Jose, CA, USA). An isotype-matched negative control will be used for each sample. Forward and side scatter histograms will be used to define the lymphocytes population. CD19+ IL-10+ B cells will be gated, then the expression of CD38 and CD24 on the CD19+B cells will be detected. Bregs will be identified as CD19+ IL-10+CD24+hiCD38+hi cells.
Locations (1)
Medicine
Asyut, Egypt